Investor Relations · Company Profile · Stock Quote · Contact Us · Pierre Van Damme, M.D., Ph.D. · John D. Grabenstein, Ph.D., R.Ph. · Damian Braga · Adam Finn, M.D., ...
People also ask
Is VBI vaccines a good buy?
What is the future outlook on VBIV stock?
Why did VBIV stock drop?
Who owns VBIV?
Director of Corporate Communications & Investor Relations, N/A, N/A, N/A. Ms. Athena Kartsaklis, Senior VP of Finance, Chief Compliance Officer & Principal ...
The company disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, ...
Missing: relations | Show results with:relations
(Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno- ...
Get the latest insights on VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) with press releases and corporate news to help you in your trading and ...
See the latest VBI Vaccines Inc stock price (VBIV:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Check out our VBIV stock analysis, current VBIV quote, charts, and historical prices for Vbi Vaccines Inc CS stock.
Email: ir@vbivaccines.com. VBI Investor Contact. Nell Beattie. Director, Corporate Development and Investor Relations. Phone: (617) 830-3031 x128. Email ...
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
A high-level overview of VBI Vaccines Inc. (VBIV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ...
Missing: relations | Show results with:relations